Severe thrombocytopenia possibly related to readministration of eptifibatide

✍ Scribed by Fran L. Paradiso-Hardy; Mina Madan; Sam Radhakrishnan; Susan Hurden; Eric A. Cohen

• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: English
• Weight: 60 KB
• Volume: 54
• Category: Article
• ISSN: 1522-1946
• DOI: 10.1002/ccd.1239

✦ Synopsis

Abstract

Thrombocytopenia following eptifibatide therapy is a rare event, and acute severe thrombocytopenia following readministration has not been reported. We describe a case of acute severe thrombocytopenia following reexposure to eptifibatide during percutaneous coronary intervention. We continue to monitor platelet counts at 2–4 hr and 16–24 hr following administration of any glycoprotein IIb/IIIa inhibitor. Cathet Cardiovasc Intervent 2001;54:63–67. © 2001 Wiley‐Liss, Inc.